Armistice Capital’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.8M Sell
15,800,000
-1,700,000
-10% -$2.58M 0.39% 52
2025
Q4
$34.8M Buy
17,500,000
+1,900,000
+12% +$2.92M 0.41% 41
2025
Q3
$25.4M Buy
15,600,000
+3,600,000
+30% +$7.03M 0.38% 41
2025
Q2
$27.4M Buy
12,000,000
+1,000,000
+9% +$1.65M 0.47% 32
2025
Q1
$17.1M Buy
11,000,000
+1,800,000
+20% +$3.65M 0.26% 74
2024
Q4
$21.6M Buy
9,200,000
+2,328,000
+34% +$7.87M 0.3% 67
2024
Q3
$24.9M Buy
6,872,000
+622,000
+10% +$2.48M 0.4% 45
2024
Q2
$21.8M Buy
6,250,000
+1,578,000
+34% +$6.81M 0.27% 62
2024
Q1
$29.8M Buy
4,672,000
+822,000
+21% +$5.13M 0.4% 40
2023
Q4
$24.8M Sell
3,850,000
-3,050,000
-44% -$11.6M 0.34% 53
2023
Q3
$16.1M Sell
6,900,000
-364,000
-5% -$1.04M 0.25% 65
2023
Q2
$17.3M Sell
7,264,000
-2,408,000
-25% -$5.71M 0.25% 75
2023
Q1
$17.8M Sell
9,672,000
-552,000
-5% -$1.08M 0.26% 70
2022
Q4
$19.4M Buy
+10,224,000
New +$25.9M 0.34% 57

Other funds holding AUTL